drugset / Trial / NCT05785728
A Study of DB-1202 Monotherapy in Advanced Solid Tumors
Non-randomizedSequentialOpen-labelTreatment
Summary
This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1201 in subjects with advanced solid tumors.
Timeline
- Start
- 2023-06-28
- Primary completion
- 2024-02-28
- Completion
- 2024-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DB-1202 | Unknown | — | Intravenous |